Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

Fig. 1

Expression of m6A RNA methylation modulators in 140 patients with PAAD and 167 normal samples based on TCGA and GTEx database. The expression levels of 28 m6A RNA methylation modulators in patients with PAAD presented in A a heatmap (green means high expression while blue means low expression and blue means normal samples while pink means tumour samples) and B a boxplot (blue means normal samples while red means tumour samples). The association between the expression of the modulators and survival time with statistically significant C The CNV variation frequency of 28 m6A regulators in 140 patients with PAAD. D The location of CNV alteration of m6A regulators on 23 chromosomes. E Spearman’s correlation analysis of the 28 m6A RNA methylation modulators in PAAD patients. F Interaction associations among 28 m6A RNA methylation modulators are visualized in the network and the relationship between m6A regulators and prognosis. *p < 0.05, **p < 0.01, ***p < 0.001

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us